Catalyst Pharmaceuticals, Inc. (CPRX)
24.42
+0.13
(+0.54%)
USD |
NASDAQ |
Feb 19, 16:00
24.00
-0.42
(-1.72%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap : 3.002B for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rigel Pharmaceuticals, Inc. | 665.06M |
| United Therapeutics Corp. | 20.69B |
| Supernus Pharmaceuticals, Inc. | 2.944B |
| Karyopharm Therapeutics, Inc. | 177.39M |
| Krystal Biotech, Inc. | 7.617B |
Market Cap Related Metrics
| PE Ratio | 14.25 |
| PS Ratio | 5.362 |
| PEG Ratio | 0.3082 |
| Price to Book Value | 3.262 |
| Price to Free Cash Flow | 13.22 |
| Price | 24.42 |
| Earnings Yield | 7.02% |
| PEGY Ratio | 0.3082 |
| Operating PE Ratio | 11.98 |
| Normalized PE Ratio | 14.45 |